A Study of Supaglutide in Chinese Type 2 Diabetes Patients

Clinical trial NCT04314622 · COMPLETED

Trial details

NCT number: NCT04314622
Sponsor: Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2020-04-14
Primary completion: 2020-10-25
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.